دورية أكاديمية

Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice

التفاصيل البيبلوغرافية
العنوان: Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice
المؤلفون: Alessandro Del Re, Silvia Basili Franzin, Jie Lu, Irene Palenca, Aurora Zilli, Federico Pepi, Anna Troiani, Luisa Seguella, Marcella Pesce, Giovanni Esposito, Giovanni Sarnelli, Giuseppe Esposito
المصدر: Translational Medicine Communications, Vol 9, Iss 1, Pp 1-15 (2024)
بيانات النشر: BMC, 2024.
سنة النشر: 2024
المجموعة: LCC:Medicine
مصطلحات موضوعية: Engineered probiotic, Palmitoylethanolamide, SARS-CoV-2, Spike protein, ARDS, NLRP3, Medicine
الوصف: Abstract Background SARS-CoV-2 belongs to the coronaviridae family and infects human cells by directly interacting with the angiotensin-converting enzyme-2 (ACE-2) through the viral Spike Protein (SP). While vaccines are crucial, much attention has been directed towards managing the symptoms of acute respiratory distress syndrome. Our present study highlights the potential in counteracting lung inflammation triggered by SARS-CoV-2 SP of the intranasal administration of the engineered probiotic Lactobacillus paracasei F19 expressing the enzyme NAPE-PLD (pNAPE-LP) able to in situ release palmitoylethanolamide (PEA) under a super-low boost of palmitate. Methods C57BL/6J mice undergo prophylactic treatment with intranasal pNAPE-LP/palmitate for 7 days before a 7 days challenge with intranasal SARS-CoV-2 SP. Then the capability of pNAPE-LP of colonizing the lungs and actively release PEA in situ have been determined by immunofluorescence, western blot and HPLC-MS. Moreover, the innate immune system downregulation and the histological damage rescue exerted by pNAPE-LP have been tested by immunofluorescence, hematoxylin and eosin staining, western blot analysis and ELISA test for the release of the pro-inflammatory mediators. Results pNAPE-LP effectively colonizes mice lungs and releases the anti-inflammatory compound PEA. Moreover, pNAPE-LP exhibits a protective effect on alveolar morphology, innate immune cells infiltration and in the reduction of neutrophil count, effectively reducing lung injury induced by SARS-CoV-2 SP. This is achieved by mitigating TLR4-mediated NLRP3 activation and the downstream pro-inflammatory products such as ILs, TNFα, C-reactive protein and the myeloperoxidase activity. Interestingly we observed a global reduction ACE2 expression in the lungs. Conclusion pNAPE-LP actively protect from severe inflammatory-related symptoms in SP-challenged mice. Also, it can downregulate the expression of ACE-2 receptors at the lung site potentially preventing the spreading of the infection.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2396-832X
Relation: https://doaj.org/toc/2396-832X
DOI: 10.1186/s41231-024-00167-x
URL الوصول: https://doaj.org/article/7c64fe1c8cd04ea5a491de0ac91f1359
رقم الأكسشن: edsdoj.7c64fe1c8cd04ea5a491de0ac91f1359
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2396832X
DOI:10.1186/s41231-024-00167-x